No Evidence of Disease Activity Status in Patients Treated with Early Vs. Delayed Subcutaneous Interferon β-1a

ConclusionsET with scIFN β-1a tiw was associated with a higher likelihood of achieving NEDA-3 not only at 2 but also at 3 and 5 years.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research